Cargando…
Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China
Background: Robotic colorectal surgery has been increasingly performed in recent years. The safety and feasibility of its application has also been demonstrated worldwide.However, limited studies have presented clinical data for patients with colorectal cancer (CRC) receiving robotic surgery in Chin...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422034/ https://www.ncbi.nlm.nih.gov/pubmed/34504865 http://dx.doi.org/10.3389/fsurg.2021.696026 |
_version_ | 1783749203802980352 |
---|---|
author | Peng, Jianhong Li, Weihao Tang, Jinghua Li, Yuan Li, Xueying Wu, Xiaojun Lu, Zhenhai Lin, Junzhong Pan, Zhizhong |
author_facet | Peng, Jianhong Li, Weihao Tang, Jinghua Li, Yuan Li, Xueying Wu, Xiaojun Lu, Zhenhai Lin, Junzhong Pan, Zhizhong |
author_sort | Peng, Jianhong |
collection | PubMed |
description | Background: Robotic colorectal surgery has been increasingly performed in recent years. The safety and feasibility of its application has also been demonstrated worldwide.However, limited studies have presented clinical data for patients with colorectal cancer (CRC) receiving robotic surgery in China. The aim of this study is to present short-term clinical outcomes of robotic surgery and further confirm its safety and feasibility in Chinese CRC patients. Methods: The clinical data of 109 consecutive CRC patients who received robotic surgery at Sun Yat-sen University Cancer Center between June 2016 and May 2019 were retrospectively reviewed. Patient characteristics,tumor traits, treatment details, complications, pathological details, and survival status were evaluated. Results: Among the 109 patients, 35 (32.1%) had sigmoid cancer, and 74 (67.9%) had rectal cancer. Thirty-seven (33.9%) patients underwent neoadjuvant chemoradiotherapy. Ten (9.2%) patients underwent sigmoidectomy, 38 (34.9%) underwent high anterior resection (HAR), 45 (41.3%) underwent low anterior resection (LAR), and 16 (14.7%) underwent abdominoperineal resection (APR). The median surgical procedure time was 270 min (range 120–465 min). Pathologically complete resection was achieved in all patients. There was no postoperative mortality. Complications occurred in 11 (10.1%) patients, including 3 (2.8%) anastomotic leakage, 1 (0.9%) anastomotic bleeding, 1 (0.9%) pelvic hemorrhage, 4 (3.7%) intestinal obstruction, 2 (1.8%) chylous leakage, and 1 (0.9%) delayed wound union. At a median follow-up of 17 months (range 1–37 months), 1 (0.9%) patient developed local recurrence and 5 (4.6%) developed distant metastasis, with one death due to disease progression. Conclusions: Our results suggest that robotic surgery is technically feasible and safe for Chinese CRC patients, especially for rectal cancer patients who received neoadjuvant treatment. A robotic laparoscope with large magnification showed a clear surgical space for pelvic autonomic nerve preservation in cases of mesorectal edema. |
format | Online Article Text |
id | pubmed-8422034 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84220342021-09-08 Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China Peng, Jianhong Li, Weihao Tang, Jinghua Li, Yuan Li, Xueying Wu, Xiaojun Lu, Zhenhai Lin, Junzhong Pan, Zhizhong Front Surg Surgery Background: Robotic colorectal surgery has been increasingly performed in recent years. The safety and feasibility of its application has also been demonstrated worldwide.However, limited studies have presented clinical data for patients with colorectal cancer (CRC) receiving robotic surgery in China. The aim of this study is to present short-term clinical outcomes of robotic surgery and further confirm its safety and feasibility in Chinese CRC patients. Methods: The clinical data of 109 consecutive CRC patients who received robotic surgery at Sun Yat-sen University Cancer Center between June 2016 and May 2019 were retrospectively reviewed. Patient characteristics,tumor traits, treatment details, complications, pathological details, and survival status were evaluated. Results: Among the 109 patients, 35 (32.1%) had sigmoid cancer, and 74 (67.9%) had rectal cancer. Thirty-seven (33.9%) patients underwent neoadjuvant chemoradiotherapy. Ten (9.2%) patients underwent sigmoidectomy, 38 (34.9%) underwent high anterior resection (HAR), 45 (41.3%) underwent low anterior resection (LAR), and 16 (14.7%) underwent abdominoperineal resection (APR). The median surgical procedure time was 270 min (range 120–465 min). Pathologically complete resection was achieved in all patients. There was no postoperative mortality. Complications occurred in 11 (10.1%) patients, including 3 (2.8%) anastomotic leakage, 1 (0.9%) anastomotic bleeding, 1 (0.9%) pelvic hemorrhage, 4 (3.7%) intestinal obstruction, 2 (1.8%) chylous leakage, and 1 (0.9%) delayed wound union. At a median follow-up of 17 months (range 1–37 months), 1 (0.9%) patient developed local recurrence and 5 (4.6%) developed distant metastasis, with one death due to disease progression. Conclusions: Our results suggest that robotic surgery is technically feasible and safe for Chinese CRC patients, especially for rectal cancer patients who received neoadjuvant treatment. A robotic laparoscope with large magnification showed a clear surgical space for pelvic autonomic nerve preservation in cases of mesorectal edema. Frontiers Media S.A. 2021-08-19 /pmc/articles/PMC8422034/ /pubmed/34504865 http://dx.doi.org/10.3389/fsurg.2021.696026 Text en Copyright © 2021 Peng, Li, Tang, Li, Li, Wu, Lu, Lin and Pan. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Surgery Peng, Jianhong Li, Weihao Tang, Jinghua Li, Yuan Li, Xueying Wu, Xiaojun Lu, Zhenhai Lin, Junzhong Pan, Zhizhong Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China |
title | Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China |
title_full | Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China |
title_fullStr | Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China |
title_full_unstemmed | Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China |
title_short | Surgical Outcomes of Robotic Resection for Sigmoid and Rectal Cancer: Analysis of 109 Patients From a Single Center in China |
title_sort | surgical outcomes of robotic resection for sigmoid and rectal cancer: analysis of 109 patients from a single center in china |
topic | Surgery |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8422034/ https://www.ncbi.nlm.nih.gov/pubmed/34504865 http://dx.doi.org/10.3389/fsurg.2021.696026 |
work_keys_str_mv | AT pengjianhong surgicaloutcomesofroboticresectionforsigmoidandrectalcanceranalysisof109patientsfromasinglecenterinchina AT liweihao surgicaloutcomesofroboticresectionforsigmoidandrectalcanceranalysisof109patientsfromasinglecenterinchina AT tangjinghua surgicaloutcomesofroboticresectionforsigmoidandrectalcanceranalysisof109patientsfromasinglecenterinchina AT liyuan surgicaloutcomesofroboticresectionforsigmoidandrectalcanceranalysisof109patientsfromasinglecenterinchina AT lixueying surgicaloutcomesofroboticresectionforsigmoidandrectalcanceranalysisof109patientsfromasinglecenterinchina AT wuxiaojun surgicaloutcomesofroboticresectionforsigmoidandrectalcanceranalysisof109patientsfromasinglecenterinchina AT luzhenhai surgicaloutcomesofroboticresectionforsigmoidandrectalcanceranalysisof109patientsfromasinglecenterinchina AT linjunzhong surgicaloutcomesofroboticresectionforsigmoidandrectalcanceranalysisof109patientsfromasinglecenterinchina AT panzhizhong surgicaloutcomesofroboticresectionforsigmoidandrectalcanceranalysisof109patientsfromasinglecenterinchina |